Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
1 drug for “Metastatic Uveal Melanoma”
Phase 2/3 1
- IDE196IDEAYA Biosciences, Inc.Metastatic Uveal Melanoma
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.